- Home
- DTIL vs MVIS Comparison
DTIL vs MVIS Comparison
Compare DTIL & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTIL | MVIS |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.3M | 186.2M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | DTIL | MVIS |
|---|---|---|
| Price | $7.01 | $0.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $45.00 | $2.25 |
| AVG Volume (30 Days) | 232.9K | ★ 3.4M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.91 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | $664,000.00 |
| Revenue This Year | N/A | $529.06 |
| Revenue Next Year | N/A | $168.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.53 | $0.51 |
| 52 Week High | $8.82 | $1.73 |
Technical Indicators
Market Signals| Indicator | DTIL | MVIS |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 49.45 |
| Support Level | $4.56 | $0.51 |
| Resistance Level | $7.84 | $0.73 |
| Average True Range (ATR) | 0.53 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 59.50 | 51.89 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.